AGT Biosciences changes name to Chemgenex

By Melissa Trudinger
Tuesday, 29 June, 2004

AGT Biosciences has completed the last step in its merger with ChemGenex Therapeutics with the official name change of the company going through. Approval by AGT shareholders was obtained last week at an EGM.

From today, the company is to be known as ChemGenex Pharmaceuticals and will carry the ASX stock symbol 'CXS'.

Novel glycopeptide antibiotic candidate shows promise

Researchers have discovered a new type of glycopeptide antibiotic known as saarvienin A, found to...

Why a gluten-free diet fails in some coeliac patients

Abnormal immune cells are driving ongoing intestinal inflammation that causes symptoms like...

Giving rotavirus vaccine at birth benefits gut bacteria

Babies who receive a RV3-BB rotavirus vaccine at birth appear to show higher levels of good...

Content from other channels on our network

Head to toe: operating room workwear essentials

Immediate action needed for private hospital sector

NSW reforms to see trained GPs treat and diagnose ADHD

Raising 'tech neck' awareness this Spinal Health Week

Queensland Health faces alleged racial discrimination

Pet food maker increases production with additional palletiser

US research found 'forever chemicals' in beer

From grain processing waste to high-value products

Australian innovation tackling a recycling blind spot with wine closures

Sustainable packaging a key strategy and bottleneck for F&B brands: new research

Community-scale energy solutions encouraged by AEMO report

Nearmap and RenewMap partner to support project planning

Swinburne scientists turn cereal waste into wound dressing

Australian landfills near breaking point

Deakin and Country Road create high-value fine Merino yarn